€107.40 ABVX.PA stock pre-market: earnings due Mar 23 may reset targets

We see ABVX.PA stock trading at €107.40 in pre-market trade on 19 Mar 2026, ahead of an earnings report due 23 Mar 2026. Traders will watch revenue and clinical updates for ABIVAX SA as the company remains a biotech growth story. Volatility is likely; the stock is off -2.01% today and faces mixed analyst targets and model forecasts.